In Silico Post Genome-Wide Association Studies Analysis of C-Reactive Protein Loci Suggests an Important Role for Interferons

Circulation: Cardiovascular Genetics

Volumn 8, Issue 3, 2015, Pages 487-497

  Vaez, Ahmad ^a,d   Jansen, Rick ^b   Prins, Bram P ^a   Hottenga, Jouke Jan ^b,c   De Geus, Eco J C ^b,c   Boomsma, Dorret I ^b,c   Penninx, Brenda W J H ^b   Nolte, Ilja M ^a   Snieder, Harold ^a   Alizadeh, Behrooz Z ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; genome wide association study; interferon

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN C1; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CARNITINE TRANSPORTER 1; FATTY ACID; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 6 RECEPTOR; LOW DENSITY LIPOPROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOINFORMATICS; COMPUTER MODEL; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMEOSTASIS; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLEIOTROPY; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE TRAIT LOCUS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; WAIST CIRCUMFERENCE; ALLELE; DNA SEQUENCE; GENETICS; LONGITUDINAL STUDY; METABOLISM;

ALLELES; C-REACTIVE PROTEIN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INTERFERONS; LINKAGE DISEQUILIBRIUM; LONGITUDINAL STUDIES; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; SEQUENCE ANALYSIS, DNA;

EID: 84936936885     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.114.000714     Document Type: Article

References (67)

1. Nordestgaard BG., Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere. Curr Opin Lipidol 2009 20 393 401. doi: 10.1097/MOL.0b013e3283307bfe.
2. Allin KH, Bojesen SE, Nordestgaard BG., Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009 27 2217 2224. doi: 10.1200/JCO.2008.19.8440.
3. Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 2007 56 872 878. doi: 10.2337/db06-0922.
4. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM., C-reactive protein and the risk of developing hypertension. JAMA 2003 290 2945 2951. doi: 10.1001/jama.290.22.2945.
5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004 350 1387 1397. doi: 10.1056/NEJMoa032804.
6. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010 375 132 140
7. De Berardis D, Conti CM, Campanella D, Carano A, Scali M, Valchera A, Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder. Int J Immunopathol Pharmacol 2008 21 319 324
8. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999 106 506 512
9. Tremblay J., Genetic determinants of C-reactive protein levels in metabolic syndrome: a role for the adrenergic system? J Hypertens 2007 25 281 283. doi: 10.1097/HJH.0b013e328013dc13.
10. Ummarino D, Zeng L., Is C reactive protein expression affected by local microenvironment? Heart 2013 99 514 515. doi: 10.1136/heartjnl-2012-303436.
11. Danik JS, Ridker PM., Genetic determinants of C-reactive protein. Curr Atheroscler Rep 2007 9 195 203
12. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009 302 37 48. doi: 10.1001/jama.2009.954.
13. Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney JF Jr, Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006 113 1415 1423. doi: 10.1161/CIRCULATIONAHA.105.591271.
14. Saunders CL, Gulliford MC., Heritabilities and shared environmental effects were estimated from household clustering in national health survey data. J Clin Epidemiol 2006 59 1191 1198. doi: 10.1016/j.jclinepi.2006.02.015.
15. Rahman I, Bennet AM, Pedersen NL, de Faire U, Svensson P, Magnusson PK., Genetic dominance influences blood biomarker levels in a sample of 12,000 Swedish elderly twins. Twin Res Hum Genet 2009 12 286 294. doi: 10.1375/twin.12.3.286.
16. Su S, Miller AH, Snieder H, Bremner JD, Ritchie J, Maisano C, Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study. Psychosom Med 2009 71 152 158. doi: 10.1097/PSY.0b013e31819082ef.
17. Neijts M, van Dongen J, Kluft C, Boomsma DI, Willemsen G, de Geus EJ., Genetic architecture of the pro-inflammatory state in an extended twin-family design. Twin Res Hum Genet 2013 16 931 940. doi: 10.1017/thg.2013.58.
18. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, Buring JE, Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008 82 1185 1192. doi: 10.1016/j.ajhg.2008.03.015.
19. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011 123 731 738. doi: 10.1161/CIRCULATIONAHA.110.948570.
20. Wang X, Prins BP, Sõber S, Laan M, Snieder H., Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension. Curr Hypertens Rep 2011 13 442 451. doi: 10.1007/s11906-011-0230-y.
21. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011 43 513 518. doi: 10.1038/ng.840.
22. Franceschini N, van Rooij FJ, Prins BP, Feitosa MF, Karakas M, Eckfeldt JH, Discovery and fine mapping of serum protein loci through transethnic meta-analysis. Am J Hum Genet 2012 91 744 753. doi: 10.1016/j.ajhg.2012.08.021.
23. 1000 Genomes Project Consortium Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, 1000 Genomes Project Consortium A map of human genome variation from population-scale sequencing. Nature 2010 467 1061 1073. doi: 10.1038/nature09534.
24. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 2013 41 Database issue D64 D69. doi: 10.1093/nar/gks1048.
25. Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, 1000 Genomes Project Analysis Group The variant call format and VCFtools. Bioinformatics 2011 27 2156 2158. doi: 10.1093/bioinformatics/btr330.
26. Li H., Tabix: fast retrieval of sequence features from generic TAB-delimited files. Bioinformatics 2011 27 718 719. doi: 10.1093/bioinformatics/btq671.
27. Wang K, Li M, Hakonarson H., ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010 38 e164. doi: 10.1093/nar/gkq603.
28. Kumar P, Henikoff S, Ng PC., Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009 4 1073 1081. doi: 10.1038/nprot.2009.86.
29. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, A method and server for predicting damaging missense mutations. Nat Methods 2010 7 248 249. doi: 10.1038/nmeth0410-248.
30. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Ensembl 2012. Nucleic Acids Res 2012 40 Database issue D84 D90. doi: 10.1093/nar/gkr991.
31. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009 106 9362 9367. doi: 10.1073/pnas.0903103106.
32. Jansen R, Batista S, Brooks AI, Tischfield JA, Willemsen G, van Grootheest G, Sex differences in the human peripheral blood transcriptome. BMC Genomics 2014 15 33. doi: 10.1186/1471-2164-15-33.
33. Wright FA, Sullivan PF, Brooks AI, Zou F, Sun W, Xia K, Heritability and genomics of gene expression in peripheral blood. Nat Genet 2014 46 430 437. doi: 10.1038/ng.2951.
34. Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P, NESDA Research Consortium The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008 17 121 140. doi: 10.1002/mpr.256.
35. Boomsma DI, de Geus EJ, Vink JM, Stubbe JH, Distel MA, Hottenga JJ, Netherlands Twin Register: from twins to twin families. Twin Res Hum Genet 2006 9 849 857. doi: 10.1375/183242706779462426.
36. Boomsma DI, Willemsen G, Sullivan PF, Heutink P, Meijer P, Sondervan D, Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects. Eur J Hum Genet 2008 16 335 342. doi: 10.1038/sj.ejhg.5201979.
37. Abdellaoui A, Hottenga JJ, de Knijff P, Nivard MG, Xiao X, Scheet P, Population structure, migration, and diversifying selection in the Netherlands. Eur J Hum Genet 2013 21 1277 1285. doi: 10.1038/ejhg.2013.48.
38. Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, Bonder MJ, Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 2011 7 e1002197. doi: 10.1371/journal.pgen.1002197.
39. Westra HJ, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013 45 1238 1243. doi: 10.1038/ng.2756.
40. Visscher PM, Benyamin B, White I., The use of linear mixed models to estimate variance components from data on twin pairs by maximum likelihood. Twin Res 2004 7 670 674. doi: 10.1375/1369052042663742.
41. Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q., GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol 2008 9 Suppl 1 S4. doi: 10.1186/gb-2008-9-s1-s4.
42. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang PL, Lotia S, A travel guide to Cytoscape plugins. Nat Methods 2012 9 1069 1076. doi: 10.1038/nmeth.2212.
43. Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, Donaldson SL, GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 2010 26 2927 2928. doi: 10.1093/bioinformatics/btq562.
44. Mostafavi S, Morris Q., Combining many interaction networks to predict gene function and analyze gene lists. Proteomics 2012 12 1687 1696. doi: 10.1002/pmic.201100607.
45. Schröder MS, Gusenleitner D, Quackenbush J, Culhane AC, Haibe-Kains B., RamiGO: an R/Bioconductor package providing an AmiGO visualize interface. Bioinformatics 2013 29 666 668. doi: 10.1093/bioinformatics/bts708.
46. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Circos: an information aesthetic for comparative genomics. Genome Res 2009 19 1639 1645. doi: 10.1101/gr.092759.109.
47. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000 25 25 29. doi: 10.1038/75556.
48. Enocsson H, Sjöwall C, Skogh T, Eloranta ML, Rönnblom L, Wetterö J., Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares? Arthritis Rheum 2009 60 3755 3760. doi: 10.1002/art.25042.
49. Theofilopoulos AN, Baccala R, Beutler B, Kono DH., Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005 23 307 336. doi: 10.1146/annurev.immunol.23.021704.115843.
50. Lech M, Rommele C, Anders HJ., Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3. Nephrol Dial Transplant 2013 28 803 811. doi: 10.1093/ndt/gfs448.
51. Becker GJ, Waldburger M, Hughes GR, Pepys MB., Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 1980 39 50 52
52. Honig S, Gorevic P, Weissmann G., C-reactive protein in systemic lupus erythematosus. Arthritis Rheum 1977 20 1065 1070
53. Nikpour M, Gladman DD, Ibañez D, Urowitz MB., Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus. Lupus 2009 18 966 973. doi: 10.1177/0961203309105130.
54. Sasaki K, Fujita I, Hamasaki Y, Miyazaki S., Differentiating between bacterial and viral infection by measuring both C-reactive protein and 2'-5'-oligoadenylate synthetase as inflammatory markers. J Infect Chemother 2002 8 76 80. doi: 10.1007/s101560200010.
55. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997 145 408 415
56. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001 44 2331 2337
57. Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA., Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993 20 815 821
58. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC., C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996 312 1061 1065
59. Kraja AT, Province MA, Arnett D, Wagenknecht L, Tang W, Hopkins PN, Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutr Metab (Lond) 2007 4 28. doi: 10.1186/1743-7075-4-28.
60. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP., Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000 152 897 907
61. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR., Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 347 1557 1565. doi: 10.1056/NEJMoa021993.
62. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB., Rare variants create synthetic genome-wide associations. PLoS Biol 2010 8 e1000294. doi: 10.1371/journal.pbio.1000294.
63. Anderson CA, Soranzo N, Zeggini E, Barrett JC., Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol 2011 9 e1000580. doi: 10.1371/journal.pbio.1000580.
64. Wray NR, Purcell SM, Visscher PM., Synthetic associations created by rare variants do not explain most GWAS results. PLoS Biol 2011 9 e1000579. doi: 10.1371/journal.pbio.1000579.
65. Orozco G, Barrett JC, Zeggini E., Synthetic associations in the context of genome-wide association scan signals. Hum Mol Genet 2010 19 R2 R137 R144. doi: 10.1093/hmg/ddq368.
66. Visscher PM, Brown MA, McCarthy MI, Yang J., Five years of GWAS discovery. Am J Hum Genet 2012 90 7 24. doi: 10.1016/j.ajhg.2011.11.029.
67. Voight BF, Pritchard JK., Confounding from cryptic relatedness in case-control association studies. PLoS Genet 2005 1 e32. doi: 10.1371/journal.pgen.0010032.